Achieve Life Sciences ACHV Ratios & Valuation
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Returns | ||||||
| Return on equity | -496.1%-342pp | -257.7%— | -161.1%+25.0pp | -120.1%-14.2pp | -154.5%-45.1pp | |
| Liquidity | ||||||
| Current ratio | 2.6×-0.9× | 4.4×-1.1× | 5.1×-1.6× | 6.6×+2.1× | 3.5×+0.2× | |
| Leverage | ||||||
| Debt-to-equity | 0.5×+0.4× | 0.2×+0.2× | 0×0.0× | 0×-0.2× | 0.1×-0.2× | |
| Per Share | ||||||
| Book value per share | $0.20-32.5% | $0.49-24.2% | $0.66-27.9% | $1.20-2.5% | $0.30-85.0% | |
| Valuation | ||||||
| Market capitalization | $585.16M+404% | $264.57M+119% | $160.98M-1.1% | $132.15M-18.1% | $92.61M-40.5% | |
| Price / book | 54.8×+43.5× | 12.3×+6.5× | 4.8×-0.4× | 3.2×-0.6× | 9×+5.9× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Achieve Life Sciences's ratios come from?
- Every ratio is computed from Achieve Life Sciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.